Collection Details : Oncology Times
Oncology Times reports essential clinical news for oncologists, hematologists and other cancer care
Related Articles
Intricacies of EGFR-Mutated NSCLC Care From the Patient Perspective
Alexander Spira, MD, and Julia Lazo, RN, spoke with Melinda Reubens, who was diagnosed with EGFR-mutant NSCLC, and her husband Justin.
inMIND trial: Tafasitamab plus lenalidomide and rituximab for R/R FL
During the 66th ASH Annual Meeting and Exposition, the Lymphoma Hub was pleased to speak to Stefano Luminari about the latest updates from the inMIND…
Menin inhibitors in the treatment of acute myeloid leukemia
In this Blood Spotlight, Huls et al highlight why small molecule inhibitors of menin are creating excitement in the acute myeloid leukemia (AML) field with
Nivolumab Plus Chemo Shows Long-Term OS Benefit in Chinese Patients With Advanced Gastric, GEJ, or Esophageal Cancer
Nivolumab plus chemotherapy demonstrated long-term survival benefits in advanced gastric, GEJ, or esophageal cancer in China.
Biomarker-Directed Radiotherapy in Breast Cancer
This narrative review explores the potential of biomarker-directed personalized radiotherapy approaches.
Maintenance Galinpepimut-S Appears Effective and Safe in AML in Second CR
Galinpepimut-S demonstrated early efficacy signals in patients with acute myeloid leukemia in second complete remission or later.
The 5th Annual OncoAlert Colloquium
The Year in Review in Oncology 2024 brought to you by some of the Worlds TOP experts!
A retrospective study of autoSCT outcomes in older adults with R/R classic Hodgkin lymphoma
Sanjal Desai, MBBS, Mayo Clinic, Rochester, MN, presents the findings of a multi-center international retrospective study that investigated the outcomes of autologous stem cell transplantation…
ALASCCA: adjuvant aspirin in colorectal cancer
The randomized ALASCCA trial (NCT02647099) investigated the effect of low-dose aspirin in patients with stage II and III colorectal cancer and PIK3CA mutations. Anna Martling,…
